NCT02091895

Brief Summary

The aims of this research are to validate and develop of therapeutic strategies for patients with colorectal lesions in real time through pCLE(probe-based confocal laser endomicroscopy). Endomicroscopy is a technique for obtaining histology-like images from inside the human body in real-time. Total objections are 311 patients. Specific research topics are as below.

  1. 1.Diagnosis and classification of colon polyps through pCLE
  2. 2.Evaluation of the depth of invasion of colorectal cancer or lateral growth type tumor through the pCLE
  3. 3.Differential diagnosis of colorectal submucosal tumor through the pCLE
  4. 4.Differential diagnosis of ileocecal ulcers through the pCLE

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
311

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2014

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

March 16, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 19, 2014

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2020

Completed
Last Updated

March 13, 2019

Status Verified

March 1, 2019

Enrollment Period

5.9 years

First QC Date

March 16, 2014

Last Update Submit

March 12, 2019

Conditions

Keywords

probe-based confocal laser endomicroscopy, lower gastrointestinal disorders

Outcome Measures

Primary Outcomes (1)

  • Sensitivity of pCLE diagnosis

    The study will be conducted to measure sensitivity, specificity, accuracy, amphoteric predict of pCLE diagnosis, and calculate the agreement of prediction compared to the pathological findings of lesions.

    2 weeks

Secondary Outcomes (3)

  • Specificity of pCLE diagnosis

    2 weeks

  • Accuracy of pCLE diagnosis

    2 weeks

  • amphoteric predict of pCLE diagnosis

    2 weeks

Study Arms (1)

endo group

EXPERIMENTAL

colon polyp, early colon cancer, colorectal submucosal tumor, ileocecal ulcers

Procedure: probe-based confocal laser endomicroscopy

Interventions

After shooting 10% fluorescein sodium in,2.5-5 .0 ml to the object with colorectal disease, the lesion will observed and evaluated with pCLE in real-time and also stored the inspection images. Then, determines the treatment plan to determine which is applied currently in clinical, Sensitivity, specificity, accuracy, amphoteric predict of pCLE diagnosis, and calculate the agreement of prediction compared to the pathological findings of lesions Based on the inspection image stored, using Delphi approach tests, two or more are discussed, to derive a significant technical phrases. Check diagnostic agreement of technical phrases which are derived, the matching degree between observers, and developed a new classification method based on this.

endo group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults over 20 years old
  • Patients with colorectal polyps
  • Patients who undergo endoscopic submucosal dissection (ESD) due to lateral spreading tumors or early colorectal cancer
  • Patients with submucosal tumor in colorectal cancer
  • Patients with ileocecal ulcers
  • Patients who consented to research

You may not qualify if:

  • Patients who are impossible to biopsy or polypectomy due to underlying diseases.
  • Patients who are not able to end the ESD because of a complication
  • Patients who are already known the cause of ileocecal ulcers before the pCLE.
  • Patients with contraindications to the use of disease fluorescent contrast agents
  • Patients who did not consent to research
  • Patients who are unsuitable for clinical trials in charge of the attending physician.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Severance hospital

Seoul, 120-752, South Korea

RECRUITING

Central Study Contacts

Tae Il Kim, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 16, 2014

First Posted

March 19, 2014

Study Start

March 1, 2014

Primary Completion

February 1, 2020

Study Completion

February 1, 2020

Last Updated

March 13, 2019

Record last verified: 2019-03

Locations